| Year |
Citation |
Score |
| 2018 |
Grunkemeyer TJ, Mata DG, Doddapaneni K, Murali S, Magliery TJ. Insights into the mechanism of paraoxonase-1: Comparing the reactivity of the six-bladed β-propeller hydrolases. Biochemistry. PMID 30547569 DOI: 10.1021/Acs.Biochem.8B01115 |
0.373 |
|
| 2015 |
Rezk PE, Zdenka P, Sabnekar P, Kajih T, Mata DG, Wrobel C, Cerasoli DM, Chilukuri N. An in vitro and in vivo evaluation of the efficacy of recombinant human liver prolidase as a catalytic bioscavenger of chemical warfare nerve agents. Drug and Chemical Toxicology. 38: 37-43. PMID 24641262 DOI: 10.3109/01480545.2014.900071 |
0.314 |
|
| 2010 |
Ying H, Baldauff RM, Vyas S, Harsch CIK, Mata DG, Hadad CM, Magliery TJ, Gustafson TL. Functional analyses of human serum paraoxonase (HuPON1) mutants using drop coating deposition Raman difference spectroscopy Aip Conference Proceedings. 1267: 434-435. DOI: 10.1063/1.3482601 |
0.383 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2014 |
Mata DG, Rezk PE, Sabnekar P, Cerasoli DM, Chilukuri N. Investigation of evolved paraoxonase-1 variants for prevention of organophosphorous pesticide compound intoxication. The Journal of Pharmacology and Experimental Therapeutics. 349: 549-58. PMID 24706983 DOI: 10.1124/Jpet.114.213645 |
0.26 |
|
| 2016 |
Mata DG, Sabnekar P, Watson CA, Rezk PE, Chilukuri N. Assessing the stoichiometric efficacy of mammalian expressed paraoxonase-1 variant I-F11 to afford protection against G-type nerve agents. Chemico-Biological Interactions. PMID 27083144 DOI: 10.1016/J.Cbi.2016.04.013 |
0.241 |
|
| 2021 |
Gasca-Salas C, Fernández-Rodríguez B, Pineda-Pardo JA, Rodríguez-Rojas R, Obeso I, Hernández-Fernández F, Del Álamo M, Mata D, Guida P, Ordás-Bandera C, Montero-Roblas JI, Martínez-Fernández R, Foffani G, Rachmilevitch I, Obeso JA. Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia. Nature Communications. 12: 779. PMID 33536430 DOI: 10.1038/s41467-021-21022-9 |
0.067 |
|
| 2015 |
Mata D, Linn DM, Linn CL. Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors. Neuropharmacology. 99: 337-46. PMID 26239818 DOI: 10.1016/j.neuropharm.2015.07.036 |
0.054 |
|
| 2022 |
Mata D, Korpak AK, Macaulay T, Dodge B, Mustanski B, Feinstein BA. Substance Use Experiences Among Bisexual, Pansexual, and Queer (Bi+) Male Youth: A Qualitative Study of Motivations, Consequences, and Decision Making. Archives of Sexual Behavior. PMID 36271216 DOI: 10.1007/s10508-022-02447-9 |
0.022 |
|
| 2021 |
Mata D, Korpak AK, Sorensen B, Dodge B, Mustanski B, Feinstein BA. A mixed methods study of sexuality education experiences and preferences among bisexual, pansexual, and queer (bi+) male youth. Sexuality Research & Social Policy : Journal of Nsrc : Sr & Sp. 19: 806-821. PMID 35756362 DOI: 10.1007/s13178-021-00593-8 |
0.01 |
|
| 2021 |
Abramsohn EM, Paradise KM, Glover CM, Benjamins M, Douglas L, Jerome J, Kim ML, Kostas T, Mata D, Padron F, Shah RC, Lindau ST. CommunityRx: Optimizing a Community Resource Referral Intervention for Minority Dementia Caregivers. Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society. 7334648211005594. PMID 33834890 DOI: 10.1177/07334648211005594 |
0.01 |
|
| 2014 |
Iwamoto K, Birkholz P, Schipper A, Mata D, Linn DM, Linn CL. A nicotinic acetylcholine receptor agonist prevents loss of retinal ganglion cells in a glaucoma model. Investigative Ophthalmology & Visual Science. 55: 1078-87. PMID 24458148 DOI: 10.1167/Iovs.13-12688 |
0.01 |
|
| Hide low-probability matches. |